Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Hematologic Neoplasms × Abatacept × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Myasthenia Gravis 1 Hematologic Neoplasms 1

Interventions

venetoclax 1 ruxolitinib 1 isatuximab 1 Tissue Plasminogen Activator 1 Therapeutics 1 Stem Cell Transplantation 1 Psychiatric Rehabilitation 1 Oxymorphone 1 Oxycodone 1 Morphine 1 Lisaftoclax 1 Levorphanol 1 Kidney Transplantation 1 Hyperthermia, Induced 1 Hydromorphone 1 Hydrocodone 1 Diathermy 1 Counseling 1 Cell- and Tissue-Based Therapy 1 CF regimen 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06731504 2026-01-16

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Duke University

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡